Nanotechnology Now

Our NanoNews Digest Sponsors

Heifer International

Wikipedia Affiliate Button

Home > News > Finding the Right Formula

September 20th, 2010

Finding the Right Formula

Abstract:
The Biological Test Center in Irvine, Calif., which focuses on drug dosage formulations, reports that due to the insolubility of certain compounds, nanotechnology is moving to the forefront. For both commercial and experimental ophthalmic compounds, the company has seen an increase in testing of implantable drug coated or controlled-release delivery devices.

"The days when a simple salt of a molecule would provide all of the solubility and stability required appear to be behind us," says Velasco's Barnes. "This actually provides a great opportunity for formulators to save an otherwise good drug molecule from oblivion. There is also the added benefit of patent life extension to be gained by companies who invest in formulating these challenging compounds."

Companies also are looking at formulation as a way to alter toxicology profiles, change bioavailability, or deliver drugs to particular sites, according to Charles River. Time release formulations, depot formulations, formulations that are used with special devices to administer the drug, and use of nanoparticles to change the distribution of drugs in cells and tissues are becoming more and more complex.

Source:
dddmag.com

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

Unconventional superconductor may be used to create quantum computers of the future: They have probably succeeded in creating a topological superconductor February 19th, 2018

Photonic chip guides single photons, even when there are bends in the road February 16th, 2018

Arrowhead Pharmaceuticals Receives Orphan Drug Designation for ARO-AAT February 15th, 2018

European & Korean Project To Demo World’s First 5G Platform During Winter Games February 15th, 2018

Nanomedicine

Arrowhead Receives Regulatory Clearance to Begin Phase 1/2 Study of ARO-HBV for Treatment of Hepatitis B February 15th, 2018

Arrowhead Pharmaceuticals Receives Orphan Drug Designation for ARO-AAT February 15th, 2018

'Living bandages': NUST MISIS scientists develop biocompatible anti-burn nanofibers February 15th, 2018

Understanding brain functions using upconversion nanoparticles: Researchers can now send light deep into the brain to study neural activities February 14th, 2018

Nanobiotechnology

Arrowhead Receives Regulatory Clearance to Begin Phase 1/2 Study of ARO-HBV for Treatment of Hepatitis B February 15th, 2018

Arrowhead Pharmaceuticals Receives Orphan Drug Designation for ARO-AAT February 15th, 2018

'Living bandages': NUST MISIS scientists develop biocompatible anti-burn nanofibers February 15th, 2018

Understanding brain functions using upconversion nanoparticles: Researchers can now send light deep into the brain to study neural activities February 14th, 2018

NanoNews-Digest
The latest news from around the world, FREE



  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoTech-Transfer
University Technology Transfer & Patents
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project